Mega Lifesciences Public Company financials at a glance

+ Portfolio

The revenue of Mega Lifesciences Public Company is reported as 15.68117 billion Baht in the fiscal year 2023. The earnings were 3.1 Baht per share in 2023, which was 14.39 higher than 2022. And about 2.21475 billion Baht are reported as free cash flow in the financials of Mega Lifesciences Public Company 2023. Dividends of 1.48 Baht per share were paid to shareholders of Mega Lifesciences Public Company stock SET:MEGA in fiscal 2023.

฿15.68B

Revenue

฿3.10

Earnings Per Share

45.37%

Gross Margin %

฿2.10B

Free Cash Flow

Revenue

15,681.17

Earnings Per Share

3.10

Gross Margin %

45.37

Free Cash Flow

2,096.60

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Rev.	Revenue	N/A	฿15.68B	฿15.69B	฿14.30B	฿12.64B	฿11.18B	฿10.34B	฿9.60B	฿8.81B	฿8.10B	฿7.77B
GM %	Gross Margin %	45.43%	45.37%	45.02%	41.97%	39.72%	41.32%	43.68%	45.17%	41.96%	43.03%	40.31%
OM	Operating Margin	17.73%	18.70%	17.31%	15.37%	13.65%	12.86%	14.00%	14.36%	11.67%	8.91%	8.42%
EPS	Earnings Per Share	฿2.20	฿3.10	฿2.71	฿2.10	฿1.60	฿1.31	฿1.39	฿1.28	฿0.92	฿0.80	฿0.63
Div.	Dividends	N/A	฿1.48	฿1.61	฿1.06	฿0.90	฿0.72	฿0.71	฿0.70	฿0.47	฿0.40	฿0.35
PR %	Payout Ratio %	0	47.74%	59.41%	50.48%	56.25%	54.96%	51.08%	54.69%	51.09%	50.00%	55.56%
Sha.	Shares	N/AM	871.87M	871.87M	871.87M	871.87M	871.87M	866.77M	865.25M	865.25M	865.25M	865.25M
OCF	Operating Cash Flow	N/A	฿2.49B	฿2.00B	฿2.73B	฿1.63B	฿1.50B	฿919.36M	฿927.00M	฿1.26B	฿609.12M	฿614.22M
FCF	Free Cash Flow	N/A	฿2.10B	฿1.69B	฿2.58B	฿1.40B	฿966.60M	฿476.43M	฿702.20M	฿977.16M	฿434.23M	฿419.05M
FCFS	Free Cash Flow Per Share	฿2.63	฿1.87	฿1.93	฿2.94	฿1.58	฿1.10	฿0.18	฿0.81	฿1.11	฿0.48	฿0.50

Mega Lifesciences Public Company financials at a glance

Financials

Discover